Menopause and Cancers

Mark H. Einstein; Nanci F. Levine; Nicole S. Nevadunsky

doi:10.1016/j.ecl.2015.05.012

Menopause and Cancers

Mark H. Einstein, Nanci F. Levine, Nicole S. Nevadunsky

Obstetrics & Gynecology and Women's Health

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.

Original language	English (US)
Pages (from-to)	603-617
Number of pages	15
Journal	Endocrinology and Metabolism Clinics of North America
Volume	44
Issue number	3
DOIs	https://doi.org/10.1016/j.ecl.2015.05.012
State	Published - Sep 1 2015

Keywords

Cancer
Cancer prevention
Cancer screening
Hormone replacement
Lifestyle modification
Menopause

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ecl.2015.05.012

Cite this

@article{e696aa9ab32140279b662c048b6518da,

title = "Menopause and Cancers",

abstract = "Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.",

keywords = "Cancer, Cancer prevention, Cancer screening, Hormone replacement, Lifestyle modification, Menopause",

author = "Einstein, {Mark H.} and Levine, {Nanci F.} and Nevadunsky, {Nicole S.}",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/j.ecl.2015.05.012",

language = "English (US)",

volume = "44",

pages = "603--617",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Menopause and Cancers

AU - Einstein, Mark H.

AU - Levine, Nanci F.

AU - Nevadunsky, Nicole S.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.

AB - Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.

KW - Cancer

KW - Cancer prevention

KW - Cancer screening

KW - Hormone replacement

KW - Lifestyle modification

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=84940451829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940451829&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2015.05.012

DO - 10.1016/j.ecl.2015.05.012

M3 - Review article

C2 - 26316246

AN - SCOPUS:84940451829

SN - 0889-8529

VL - 44

SP - 603

EP - 617

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 3

ER -

Menopause and Cancers

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this